Martin A Bennett, MD | |
2520 Cherry Ave, Bremerton, WA 98310-4229 | |
(360) 377-3911 | |
Not Available |
Full Name | Martin A Bennett |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 28 Years |
Location | 2520 Cherry Ave, Bremerton, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093748964 | NPI | - | NPPES |
8253056 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207PE0004X | Emergency Medicine - Emergency Medical Services | MD00038434 (Washington) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma.
AssureRx Health, Inc., a personalized medicine company focused on pharmacogenetics to aid in the treatment of patients with psychiatric disorders, today announced that it has added a fifth gene, CYP1A2, to its laboratory-developed pharmacogenetic test.
In the current issue of the journal Circulation, a research team from the Medical University of South Carolina's (MUSC) Heart & Vascular Center report their initial experience with a novel imaging technique that enables comprehensive diagnosis of heart disease based on a single computerized tomographic (CT) scan.
Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers).
Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies.
› Verified 2 days ago
Entity Name | Kaiser Foundation Health Plan Of Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma.
AssureRx Health, Inc., a personalized medicine company focused on pharmacogenetics to aid in the treatment of patients with psychiatric disorders, today announced that it has added a fifth gene, CYP1A2, to its laboratory-developed pharmacogenetic test.
In the current issue of the journal Circulation, a research team from the Medical University of South Carolina's (MUSC) Heart & Vascular Center report their initial experience with a novel imaging technique that enables comprehensive diagnosis of heart disease based on a single computerized tomographic (CT) scan.
Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers).
Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies.
› Verified 2 days ago
Entity Name | West Sound Emergency Physicians Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568489243 PECOS PAC ID: 9234133703 Enrollment ID: O20060914000454 |
News Archive
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma.
AssureRx Health, Inc., a personalized medicine company focused on pharmacogenetics to aid in the treatment of patients with psychiatric disorders, today announced that it has added a fifth gene, CYP1A2, to its laboratory-developed pharmacogenetic test.
In the current issue of the journal Circulation, a research team from the Medical University of South Carolina's (MUSC) Heart & Vascular Center report their initial experience with a novel imaging technique that enables comprehensive diagnosis of heart disease based on a single computerized tomographic (CT) scan.
Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers).
Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Martin A Bennett, MD 2520 Cherry Ave, Bremerton, WA 98310-4229 Ph: () - | Martin A Bennett, MD 2520 Cherry Ave, Bremerton, WA 98310-4229 Ph: (360) 377-3911 |
News Archive
Comprehensive clinical genomic testing of an adolescent patient, including whole genome sequencing, helped researchers identify mutations in a single gene that drive the most common childhood melanoma.
AssureRx Health, Inc., a personalized medicine company focused on pharmacogenetics to aid in the treatment of patients with psychiatric disorders, today announced that it has added a fifth gene, CYP1A2, to its laboratory-developed pharmacogenetic test.
In the current issue of the journal Circulation, a research team from the Medical University of South Carolina's (MUSC) Heart & Vascular Center report their initial experience with a novel imaging technique that enables comprehensive diagnosis of heart disease based on a single computerized tomographic (CT) scan.
Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers).
Experimental drugs proven safe but perhaps not sufficiently effective in initial testing or against a first disease target may sit gathering dust on the shelves of pharmaceutical companies.
› Verified 2 days ago
Glen Carlson, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2520 Cherry Ave, Bremerton, WA 98310 Phone: 360-377-3911 | |
Dr. William Byrne Cogar, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4000 | |
William M Roberts, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4426 Fax: 360-475-4344 | |
Bernard Greenfeld, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1651 Ne Bentley Dr, Bremerton, WA 98311 Phone: 360-782-3400 Fax: 360-782-3440 | |
Dr. Randy L Baldwin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Boone Rd, Bremerton, WA 98312 Phone: 360-475-4426 Fax: 360-475-4344 | |
Dr. Paul Arthur Dutky, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3914 Nw Fairway Ln, Bremerton, WA 98312 Phone: 360-479-2683 Fax: 360-479-2683 |